n(1)-methylnicotinamide has been researched along with Hypoxia-Ischemia, Brain in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Hypoxia-Ischemia, Brain: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dragun, P | 1 |
| Makarewicz, D | 1 |
| Wójcik, L | 1 |
| Ziemka-Nałecz, M | 1 |
| Słomka, M | 1 |
| Zalewska, T | 1 |
1 other study available for n(1)-methylnicotinamide and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Matrix metaloproteinases activity during the evolution of hypoxic-ischemic brain damage in the immature rat. The effect of 1-methylnicotinamide (MNA).
Topics: Aging; Animals; Anti-Inflammatory Agents; Brain; Brain Chemistry; Electrophoresis, Polyacrylamide Ge | 2008 |